乳腺钼靶检查发现的浸润性癌的全身辅助治疗。
Systemic adjuvant therapy in mammographically discovered invasive cancer.
作者信息
Wood W C
机构信息
Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
出版信息
Surg Oncol Clin N Am. 1997 Apr;6(2):381-4.
PMID:9115502
Abstract
Most mammographically discovered invasive breast cancers are 1 cm or smaller in diameter. These cancers have such a favorable prognosis that systemic therapy may be inappropriate. Special histologies, micrometastatic deposits in axiliary lymph nodes, and lesions of borderline size all pose special problems of interpretation relative to the role of systemic therapy.
摘要
大多数通过乳腺钼靶检查发现的浸润性乳腺癌直径为1厘米或更小。这些癌症预后良好，以至于全身治疗可能并不合适。特殊组织学类型、腋窝淋巴结中的微转移灶以及临界大小的病变，相对于全身治疗的作用而言，都带来了特殊的解读问题。
Zotero 插件